Citations

Clear

6273 citation(s) found for "To, Andrew".

Efficacy of RestoreX after prostatectomy: open‐label phase of a randomized controlled trial
Zganjar, Andrew , Toussi, Amir , Ziegelmann, Matthew , Frank, Igor, Boorjian, Stephen A. , Tollefson, Matthew K. , Köhler, Tobias , Trost, Landon , Tollefson, Matthew

Mayo Clinic

BJU International | April 23, 2023 | Volume: 132 | Issue: 2 | Pages: 217-226

10.1111/bju.16033 | PMID 37088866 Get It

Objective To report open‐label phase data from a recent randomized controlled trial (RCT), after previous data from that study showed improved penile length and erectile function among post‐prostatectomy men treated with Restorex penile traction therapy (RxPTT). Materials and Methods An RCT (NCT05244486) was performed to evaluate RxPTT vs no treatment (Tx) for 5 months, which was followed by a 3‐month open‐label phase. Men were stratified based on as‐treated data: Group 1 = No Tx; Group 2 = No Tx → Tx; Group 3 = Tx → No Tx; Group 4 = Tx. Assessments included stretched penile length and standardized (International Index of Erectile Function [IIEF]) and non‐standardized questionnaires. Results A total of 82 men were enrolled (mean age 58.6 years) with 9‐month data available in 45 of the men. Baseline characteristics were similar among the cohorts. Comparing Group 1 and Group 4 (respectively), notable differences included: IIEF Erectile Function domain (IIEF‐EF) score (−8 vs −0.5; P = 0.16), penile length (−0.1 vs +1.7 cm; P < 0.01), intracavernosal injection use (86% vs 14%; P < 0.01), Sexual Encounter Profile (SEP) Question 2 (50% vs 100%; P < 0.01), SEP Question 3 (33% vs 100%; P < 0.01). Men who crossed over to Tx (Group 2) failed to achieve equivalent improvements in length (+0.5 cm) or sexual function (IIEF‐EF score −6) compared to men treated early (Groups 3 and 4). Those who crossed over to no treatment after initial treatment (Group 3) experienced preserved length (+1.8 cm), and erectile function (IIEF‐EF score +0) despite therapy discontinuation. Conclusions Use of RxPTT beginning 1 month post‐prostatectomy results in improved penile length and erectile function, with benefits maintained after discontinuing therapy. If confirmed, these results represent the first postoperative therapy shown in a RCT to improve erectile function post‐prostatectomy. External validation is warranted.
Teaching NeuroImages: Linear Radial Periventricular Enhancement in Glial Fibrillary Acidic Protein Astrocytopathy
Kong, Yongyao , Koh, Odelia S.Q., Purohit, Bela, Ζεκερίδου, Αναστασία , Ng, Adeline Su Lyn , Ng, Adeline S L , McKeon, Andrew , Chiew, Yi Rong , Chin, Chee Fang

Mayo Clinic

Neurology | April 21, 2023 | Volume: 100 | Issue: 16_supplement_1 | Pages: No page available

10.1212/wnl.0000000000207021 Get It

Teaching Neuro Images : Hydroxychloroquine-induced vacuolar myopathy
Ghosh, Partha S. , Swift, D. J., Engel, Andrew G. , Swift, David

Mayo Clinic

Neurology | April 21, 2023 | Volume: 100 | Issue: 16_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206958 Get It

Teaching Video NeuroImages: Acquired focal neuromyotonia in LGI-1 autoimmunity
López‐Chiriboga, A. Sebastian , Matsumoto, Joseph Y., Sorenson, Eric J. , Klein, Christopher J. , McKeon, Andrew

Mayo Clinic

Neurology | April 21, 2023 | Volume: 100 | Issue: 16_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206956 Get It

Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods Study
Frazee, Erin N. , Chitre, Pooja N., Shepel, Kathryn, Aziz, Mohd. Hafiz Abdul, Ausman, Sara , Moreland-Head, Lindsay N, Jannetto, Paul J. , Mara, Kristin C. , Boehmer, Kasey R. , Shepel, Kathryn K, Ausman, Sara E., Mara, Kristin C , Chitre, Pooja , Pine, Kathleen H. , Rule, Andrew D. , Al‐Shaer, Mohammad H. , Abdul-Aziz, Mohd Hafiz , Roberts, Jason A , Scheetz, Marc H. , Ausman, Sara E , Rivera, Christina G.

Mayo Clinic

Therapeutic Drug Monitoring | April 20, 2023 | Volume: 45 | Issue: 4 | Pages: 508-518

10.1097/ftd.0000000000001059 | PMID 37076424 Get It

Background: Beta-lactam therapeutic drug monitoring (BL TDM; drug level testing) can facilitate improved outcomes in critically ill patients. However, only 10%–20% of hospitals have implemented BL TDM. This study aimed to characterize provider perceptions and key considerations for successfully implementing BL TDM. Methods: This was a sequential mixed-methods study from 2020 to 2021 of diverse stakeholders at 3 academic medical centers with varying degrees of BL TDM implementation (not implemented, partially implemented, and fully implemented). Stakeholders were surveyed, and a proportion of participants completed semistructured interviews. Themes were identified, and findings were contextualized with implementation science frameworks. Results: Most of the 138 survey respondents perceived that BL TDM was relevant to their practice and improved medication effectiveness and safety. Integrated with interview data from 30 individuals, 2 implementation themes were identified: individual internalization and organizational features. Individuals needed to internalize, make sense of, and agree to BL TDM implementation, which was positively influenced by repeated exposure to evidence and expertise. The process of internalization appeared more complex with BL TDM than with other antibiotics (ie, vancomycin). Organizational considerations relevant to BL TDM implementation (eg, infrastructure, personnel) were similar to those identified in other TDM settings. Conclusions: Broad enthusiasm for BL TDM among participants was found. Prior literature suggested that assay availability was the primary barrier to implementation; however, the data revealed many more individual and organizational attributes, which impacted the BL TDM implementation. Internalization should particularly be focused on to improve the adoption of this evidence-based practice.
Clinical Features, Non-Contrast CT Radiomic and Radiological Signs in Models for the Prediction of Hematoma Expansion in Intracerebral Hemorrhage
Chen, Zejia , Zhang, Liying , Carrington, André , Thornhill, Rebecca E. , Miguel, Olivier, Auriat, Angela M. , Omid‐Fard, Nima , Hiremath, Shivaprakash B. , Abitbul, Vered Tshemeister, Morotti, Andrea , Casetta, Ilaria , Fainardi, Enrico , Elkabouli, Marah, Talbot, Zoé, Chen, Zejia Frank , Carrington, André M , Thornhill, Rebecca , Hiremath, Shivaprakash , Tshemeister Abitbul, Vered , Dowlatshahi, Dar , Demchuk, Andrew M. , Gladstone, David J. , Huynh, Thien , Melkus, Gerd , Aviv, Richard Ivan

Mayo Clinic

Canadian Association of Radiologists Journal | April 18, 2023 | Volume: 74 | Issue: 4 | Pages: 713-722

10.1177/08465371231168383 | PMID 37070854 Get It

Purpose Rapid identification of hematoma expansion (HE) risk at baseline is a priority in intracerebral hemorrhage (ICH) patients and may impact clinical decision making. Predictive scores using clinical features and Non-Contract Computed Tomography (NCCT)-based features exist, however, the extent to which each feature set contributes to identification is limited. This paper aims to investigate the relative value of clinical, radiological, and radiomics features in HE prediction. Methods Original data was retrospectively obtained from three major prospective clinical trials [“Spot Sign” Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy (SPOTLIGHT)NCT01359202; The Spot Sign for Predicting and Treating ICH Growth Study (STOP-IT)NCT00810888] Patients baseline and follow-up scans following ICH were included. Clinical, NCCT radiological, and radiomics features were extracted, and multivariate modeling was conducted on each feature set. Results 317 patients from 38 sites met inclusion criteria. Warfarin use (p=0.001) and GCS score (p=0.046) were significant clinical predictors of HE. The best performing model for HE prediction included clinical, radiological, and radiomic features with an area under the curve (AUC) of 87.7%. NCCT radiological features improved upon clinical benchmark model AUC by 6.5% and a clinical & radiomic combination model by 6.4%. Addition of radiomics features improved goodness of fit of both clinical (p=0.012) and clinical & NCCT radiological (p=0.007) models, with marginal improvements on AUC. Inclusion of NCCT radiological signs was best for ruling out HE whereas the radiomic features were best for ruling in HE. Conclusion NCCT-based radiological and radiomics features can improve HE prediction when added to clinical features.
Perioperative Cyclooxygenase Inhibition and Postoperative Pancreatic Fistula After Pancreatoduodenectomy: A Systematic Review and Meta-analysis of Comparative Studies
Thomas, Jonathan Christian, Deneve, Jeremiah L. , Dickson, Paxton V. , Fleming, Andrew, Drake, Justin A. , Glazer, Evan S. , Yakoub, Danny

Mayo Clinic

Journal of the American College of Surgeons | April 17, 2023 | Volume: 236 | Issue: 5 | Pages: S65-S65

10.1097/01.xcs.0000932860.59570.50 Get It

Operative Efficiency of Thoracoabdominal Hepatectomy for Right-sided Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
Lawson, Damon Izaac, Phillips, Alisa L. , Fleming, Andrew, Drake, Justin A. , Murphy, Andrew James , Yakoub, Danny , Glazer, Evan S.

Mayo Clinic

Journal of the American College of Surgeons | April 17, 2023 | Volume: 236 | Issue: 5 | Pages: S64-S65

10.1097/01.xcs.0000932852.89502.f6 Get It

Continuous Suture vs Interrupted Suture Duct-to-mucosa Pancreatojejunostomy After Pancreatoduodenectomy: A Systematic Review and Meta-analysis of Comparative Studies
Thomas, Jonathan Christian, Deneve, Jeremiah L. , Dickson, Paxton V. , Fleming, Andrew, Drake, Justin A. , Glazer, Evan S. , Yakoub, Danny

Mayo Clinic

Journal of the American College of Surgeons | April 17, 2023 | Volume: 236 | Issue: 5 | Pages: S59-S59

10.1097/01.xcs.0000932792.21130.bf Get It

Low‐grade adenosquamous carcinoma of the breast: a clinical, morphological and immunohistochemical analysis of 25 patients
Lewis, Gloria J., Fong, Nancy, Gjeorgjievski, Sandra Gjorgova , Li, Xiaoxian , Li, Zaibo , Wei, Shi, Sturgis, Charles D. , Wang, Chunjie , Komforti, Miglena K. , Downs, Erinn, Cui, Xiaoyan , Rowe, J. Jordi, Zhang, Gloria, Komforti, Miglena, Hoda, Raza S , Zhang, Gloria , Lewis, Gloria, Zhang, Huina , McIntire, Patrick J. , Hoda, Raza S. , Sciallis, Andrew P.

Mayo Clinic

Histopathology | April 17, 2023 | Volume: 83 | Issue: 2 | Pages: 252-263

10.1111/his.14917 | PMID 37067767 Get It

AimsDue to its rarity and non‐specific clinical and pathological features, low‐grade adenosquamous carcinoma (LGASC) of the breast continues to pose diagnostic challenges. Unlike other triple‐negative breast carcinomas, LGASC tends to have an indolent clinical behaviour. It is essential to recognise this lesion for accurate diagnosis and appropriate management.Methods and resultsTwenty‐five cases of LGASC were identified in our archives and collaborating institutes. Cases of LGASC with dominant coexisting other type carcinomas were excluded. We studied the clinical presentation, morphological features, patterns of the commonly used immunohistochemical stains and follow‐up. In our cohort, LGASC was commonly located at the outer aspect of the breast and associated with intraductal papilloma. The morphology of LGASC is characterised by infiltrating small glands and nests with variable squamous differentiation. We also found cuffing desmoplastic (fibrolamellar) stromal change in 75% of patients and peripheral lymphocytic aggregates in 87.5% of patients. P63 and smooth muscle myosin (SMM) were the most common myoepithelial markers used to assist in diagnosis. P63 often stained peripheral tumour cells surrounding invasive glands (circumferential staining in 80% of the cases), mimicking myoepithelial cells. It also stained the small nests with squamous differentiation. However, SMM was negative in 63% of the cases. The vast majority of our cases were triple‐negative; only a few had focal and weak expressions of ER and PR. One patient who did not have excision developed lymph node metastasis. Most patients underwent excision or mastectomy with negative margins as surgical treatment; there were no recurrences or metastases in these patients with clinical follow‐ups up to 108 months.ConclusionsLGASC has some unique, although not entirely specific, morphological features and immunohistochemical staining patterns. Fibrolamellar stromal change, peripheral lymphocytic aggregates and variable staining of p63 and SMM are valuable features to facilitate the diagnosis.